Pre-consultation educational group intervention to improve shared decision-making in postmastectomy breast reconstruction: study protocol for a pilot randomized controlled trial by Jennica Platt et al.
TRIALS
Platt et al. Trials 2013, 14:199
http://www.trialsjournal.com/content/14/1/199STUDY PROTOCOL Open AccessPre-consultation educational group intervention
to improve shared decision-making in
postmastectomy breast reconstruction: study
protocol for a pilot randomized controlled trial
Jennica Platt, Nancy Baxter, Jennifer Jones, Kelly Metcalfe, Natalie Causarano, Stefan OP Hofer, Anne O’Neill,
Terry Cheng, Elizabeth Starenkyj and Toni Zhong*Abstract
Background: The Pre-Consultation Educational Group Intervention pilot study seeks to assess the feasibility and
inform the optimal design for a definitive randomized controlled trial that aims to improve the quality of decision-
making in postmastectomy breast reconstruction patients.
Methods/design: This is a mixed-methods pilot feasibility randomized controlled trial that will follow a single-
center, 1:1 allocation, two-arm parallel group superiority design.
Setting: The University Health Network, a tertiary care cancer center in Toronto, Canada.
Participants: Adult women referred to one of three plastic and reconstructive surgeons for delayed breast
reconstruction or prophylactic mastectomy with immediate breast reconstruction.
Intervention: We designed a multi-disciplinary educational group workshop that incorporates the key components
of shared decision-making, decision-support, and psychosocial support for cancer survivors prior to the initial
surgical consult. The intervention consists of didactic lectures by a plastic surgeon and nurse specialist on breast
reconstruction choices, pre- and postoperative care; a value-clarification exercise led by a social worker; and
discussions with a breast reconstruction patient.
Control: Usual care includes access to an informational booklet, website, and patient volunteer if desired.
Outcomes: Expected pilot outcomes include feasibility, recruitment, and retention targets. Acceptability of
intervention and full trial outcomes will be established through qualitative interviews. Trial outcomes will include
decision-quality measures, patient-reported outcomes, and service outcomes, and the treatment effect estimate and
variability will be used to inform the sample size calculation for a full trial.
Discussion: Our pilot study seeks to identify the (1) feasibility, acceptability, and design of a definitive RCT and
(2) the optimal content and delivery of our proposed educational group intervention. Thirty patients have been
recruited to date (8 April 2013), of whom 15 have been randomized to one of three decision support workshops.
The trial will close as planned in May 2013.
Trial registration: NCT01857882* Correspondence: toni.zhong@uhn.ca
UHN Breast Restoration Program, Division of Plastic and Reconstructive
Surgery, 8N 871, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada
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Women with a history of breast cancer now constitute
the largest group of cancer survivors [1], with over 85%
surviving for greater than 5 years after diagnosis [2].
Mastectomy remains a common form of breast cancer
treatment, with 37% of American women undergoing
mastectomy as their definitive cancer treatment in 2006
[3]. The goal of breast reconstruction is to reconstruct a
mastectomy defect without affecting cancer outcomes
[4]. The opportunity to restore the breast mound
through reconstructive surgery has been shown to en-
hance a woman’s self-image and femininity [5-7], as well
as provide psychosocial benefit [8].
The majority of women who undergo breast recon-
struction are satisfied with the outcome and the aes-
thetic result [5,9-11]. However, one fourth of women
report being dissatisfied with some component of their
cancer or reconstructive care [12]. Failure of the phys-
ician to provide adequate information about treatment
options is the most frequent source of cancer patient
dissatisfaction [13], and breast reconstruction patients
have expressed a need for further information regarding
the complex decision to pursue breast reconstruction
[14-16]. Information dissatisfaction and a mismatch be-
tween a patients’ preferred and actual role in decision-
making may contribute to decision regret in breast
oncology patients [12,17-19]. Implementation of strat-
egies to incorporate shared decision-making can improve
the quality of treatment decisions [20]. Developing the
self-confidence to make and express a treatment decision
(defined as decision self-efficacy [21]) is a necessary com-
ponent of shared-decision making, and this attribute can
be enhanced through decision support interventions [22].
Given the financial and time constraints that exist in
our current health-care system, it is not feasible to relay
detailed information regarding every aspect of breast re-
construction during a single patient consultation. In
addition, the breast reconstruction discussions can be
highly complex, as there are many different techniques
(implant vs. autologous tissue, one-stage vs. two-stage),
timing (delayed vs. immediate), and complications that
are unique to each procedure [4,23]. In such scenarios of
complex medical decision-making, decision support
techniques may be an effective solution to information
provision [13] and shared decision-making [14,24]. As a
result, we developed a pre-consultation educational
group intervention delivered in a group setting for
women considering breast reconstruction, with the aims
to fill an existing information-gap, promote high-quality
decision-making, and enhance decision self-efficacy.
This pilot study will be the first step in the evaluation of
our educational group intervention, and the results will
be used to determine the feasibility and inform the opti-
mal design for a definitive randomized controlled trial.Figure 1 shows a pre- and postoperative photo of a pa-
tient who underwent delayed breast reconstruction using
autologous tissue reconstruction.
Hypothesis
Patients seeking consultation for breast reconstruction
allocated to the pre-consultation educational group
intervention plus usual care will have greater decision
self-efficacy, satisfaction with information, decision pref-
erence, and decision choice, perceived involvement in
care, breast reconstruction knowledge, and less deci-
sional conflict as measured approximately 1 week after
intervention and surgical consultation compared with
patients allocated to receive usual care alone.
Pilot study objectives
1. To determine feasibility and acceptability of
randomization, intervention uptake, and data collection
2. To assess implementation and fidelity of the
outcome measures and intervention
3. To pilot trial procedures including recruitment
(giving information and obtaining preliminary
consent via telephone recruitment), randomization,
intervention delivery (workshop scheduled same day
as initial surgical consult), and outcome
measurement (mailed questionnaires)
4. To use qualitative research methods to assess the
content and acceptability of the intervention and
learn from patient interviews how to improve the
delivery of the intervention for the full trial
5. To obtain estimates of variance and a preliminary
estimate of the effect of the intervention on
preliminary trial outcomes (decision self-efficacy,
satisfaction with information, decision preference
and decision choice, decisional conflict) and service
outcomes such as duration of consultation.
Methods/design
This is a mixed-methods pilot feasibility randomized
controlled trial that will follow a single-center, 1:1 alloca-
tion, two-arm parallel group superiority design. The
study setting will be the University Health Network
(UHN), a tertiary care cancer center in Toronto, Canada,
with three plastic and reconstructive surgeons who
specialize in breast reconstruction. Research ethics
board approval was obtained from the University Health
Network (11-1027-CE).
Participants
Adult women referred to one of the plastic surgeons for
consideration of breast reconstruction will be eligible to
participate. The study coordinator is responsible for
identification and recruitment of potentially eligible
Figure 1 Delayed breast reconstruction. (A) Preoperative photograph demonstrating right mastectomy defect after post-mastectomy
radiation. (B) Postoperative photograph after delayed breast reconstruction using autologous tissue reconstruction.
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workshop) will occur before the initial surgical consult-
ation, it is necessary to identify subjects from faxed re-
ferrals and determine their eligibility via telephone
confirmation at the time of recruitment and prior to the
initial surgical consultation. Participants will be excluded
if they are referred for reconstruction after atypical
breast malignancy (e.g., angiosarcoma) or metastatic
breast cancer, secondary breast reconstruction, have cog-
nitive impairment or uncontrolled psychiatric diagnosis,
or cannot read or write in English. Once eligibility has
been confirmed with the study coordinator, subjects who
indicate an interest in participation will be enrolled afterproviding informed consent over the telephone, and
study packages will subsequently be mailed. Participants
will be officially registered upon receipt of signed con-
sent through return mail. Baseline measures (T0) will be
assessed prior to randomization and returned in
postage-paid envelopes. Participants in the study and
control groups will complete T1 measures approximately
1 week after the initial surgical consultation. The partici-
pant timeline is outlined in Figure 2.
Randomization and allocation of interventions
Once informed consent has been obtained from each
participant and the baseline questionnaire returned by
Figure 2 Study design flowchart and participant timeline.
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opened by the study coordinator to determine the partici-
pant’s randomized treatment allocation. A computer-
generated random allocation sequence will be created and
sealed in opaque envelopes by the program biostatistician
independent form the study coordinator with 1:1 alloca-
tion to the educational group intervention or usual care
and balanced in blocks of ten.
Intervention
Patients in the experimental group will participate in a
pre-consultation educational group intervention in
addition to receiving usual care. The intervention will be
2 h in duration on the morning of the consultation and
will be facilitated by a dedicated social worker from
psycho-oncology. Concerning the workshop develop-
ment and structure, the intervention will incorporate the
key components of shared decision-making (patient-
physician involvement, shared information, expression of
preferences) [13] and decision support (informationprovision, values clarification and patient involvement)
[25-27] with the philosophy of delivering supportive care
to cancer patients [28-30].
 Surgeon – 30 min: treatment options for breast
reconstruction with indications/contraindications,
advantages/disadvantages, expected postoperative
course, aesthetic result (realistic photos), and
complications with probabilities
 Registered nurse – 30 min: preparing for surgery,
postoperative recovery, and how to navigate the
health-care system
 Social worker (SW) – 30 min: values clarification
exercise (Figure 3)
 Breast reconstruction patient volunteer: 30 min:
questions and answers about her personal
experience
Patients in the experimental and control group will re-
ceive usual care. At the UHN, all patients are asked to
Figure 3 Values clarification exercise. The last component of the Pre-Consultation Educational Group Intervention is the values clarification
exercise. Using an interactive example, the purpose of the values clarification exercise is explained, and patients are invited to consider their
personal values and complete the exercise. This is brought to the surgical consultation to incorporate patient values into the shared
decision-making process.
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visit the website developed by the group prior to their
consultation with the plastic surgeons. They are then
booked for a 45-min consultation with a consultant plas-
tic surgeon and a surgical resident or fellow. A thorough
history and physical exam are performed, and specific
information regarding reconstruction options, advan-
tages, and complications is provided, followed by a dis-
cussion about patient preferences. In addition, all
patients are referred to speak with a volunteer patient at
a later date if desired. Appointments will be scheduled
in batches to prevent contamination between those ran-
domized to the experimental and control groups.
Outcome measures
Pilot and feasibility outcome measures
Feasibility and acceptability of randomization, treatment
allocation, and data-collection procedures: Recruitment
and attrition rates will be recorded. We will measure theproportion of participants that submits complete primary
and secondary outcome measures and baseline question-
naires. Treatment Implementation and fidelity: We will
record the proportion of participants who received their
randomly allocated treatment assignment to monitor
participant adherence to treatment allocation. Accept-
ability of interventions, assessment of primary outcome,
and refinement of the educational group intervention
content and delivery: A subgroup of participants allo-
cated to both the experimental and usual care groups
will be asked to participate in a brief qualitative tele-
phone interview. Purposeful sampling will be used to re-
cruit five patients from each group to achieve data
saturation and variability [31]. Telephone interviews will
be conducted by a social worker trained in qualitative
methods after the decision regarding breast reconstruc-
tion has been made, which we consider to be when a pa-
tient signs the surgical consent. All participants
randomized to the workshop will additionally be asked
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vention immediately after participation in the workshop.
Trial outcome measures will be divided into three broad
categories
Decision measures will include decision self-efficacy [21],
decision conflict score [32], decision preference, and de-
cision choice [33]. These three instruments will be given
at T0 (baseline) and T1, after the surgical consultation
with the plastic surgeon.
1) The decision self-efficacy (DSE) scale is a
prospectively designed instrument to evaluate
patient self-confidence in decision-making, including
shared decision-making [21]. It has been validated
among women facing treatment decisions for
osteoporosis [21] and used in cancer patients [22].
Psychometric evaluation has shown high levels of
internal consistency (Cronbach’s alpha 0.90).
Decision self-efficacy is correlated with decision
conflict subscales of feeling informed (r = 0.47) and
supported (r = 0.45) [21]. This instrument has never
been tested in the breast cancer or breast
reconstruction population.
2) The decision conflict scale measures personal
perceptions of uncertainty in choosing options and
has been demonstrated to be valid and responsive to
change [32]. The decisional conflict scale is a
16-item 5-response instrument that reports a score
from 0 – 100 with higher scores indicating more
conflict (items are summed, divided by 16 and
multiplied by 25) [26,34].
3) Decision Preference and Decision Choice has been
used as a primary and secondary outcome in studies
of decision support interventions in cancer patients. It
demonstrates good test-retest reliability (test-retest
coefficient > 0.90) and is sensitive to change when
measured before and after an intervention [33].
Patient reported outcomes (PRO) will be measured using
the perceived involvement in care scale [35] (PICS) and sat-
isfaction with information subscale of BREAST-Q [36-39].
1) PICS is a measure of patient perception of involvement
with her care, and has seven 5-point Likert scale items
that assess the extent to which the patient asked
questions, offered opinions, and expressed concerns
when meeting with the surgeon [35].
2) The BREAST-Q is a procedure-specific and
validated PRO that measures Hr-QOL and patient
satisfaction with PMBR [36-39]. The “Satisfaction
with Information” Subscale specifically measures
patient satisfaction with the preoperative
information and care provided by the plasticsurgeon and other members of the medical team.
There are 15 items that use a four-level Likert scale
response format; the score is transformed on a scale
of 0 to 100 with higher scores indicating greater
satisfaction [36-39].
Service outcomes will be measured using the uptake
rate of breast reconstruction, consultation length, num-
ber of consultations until a decision is made (consent
signed), the physician satisfaction scale [40], and a breast
reconstruction knowledge test [41].
Baseline measures
Patient demographic and clinical characteristics, baseline
psychosocial measures such as the Spielberger State-
Trait Anxiety Inventory (STAI) [42], a social support
survey [43], and preference for decision control [44] will
be captured on our routine two-page patient intake form
after consent but prior to randomization and allocation
(T0, Figure 1). Baseline covariates that will be docu-
mented include demographic variables, including age,
marital status, ethnicity, household annual income,
highest level of education, urban vs. nonurban place of
residence, and employment status, and clinical covari-
ates, including study site, timing of the reconstruction
(immediate vs. delayed), previous stage of breast cancer,
prior receipt of radiation, prior receipt of chemotherapy,
and presence of chronic illness.
STAI is a 20-item measure of anxiety, and its scores
range from 20–80, with a higher score indicating greater
anxiety [42]. The STAI trait subscale will be measured at
baseline, and the state subscale will be measured at base-
line and T1. The state subscale is a sensitive indicator of
changes in transitory anxiety in behavior modification
programs or with experimental procedures.
The Medical Outcomes Study Social Support Survey
has a series of 18 questions that measure four domains
of social support (emotional, tangible, affectionate, and
social interactions). Responses range from 1 (none of the
time) to 5 (all the time). The items in each domain were
summed and then transformed to yield scores ranging
from 0 to 100. Higher scores indicate more support [43].
Preference for Decision Control is assessed using a val-
idated question from previous studies in cancer patients
where patients indicate whether they want to play an ac-
tive, passive, or collaborative role with their physician
when making a treatment decision [35].
Analysis
Analysis of primary and secondary outcomes from the
main trial will be summarized using measures of central
tendency and dispersion. This pilot study will provide
important information regarding the treatment effect es-
timate and variability (standard deviation) to supplement
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be used to guide the design and sample size calculation
for the main trial. Because this is a pilot study, we do
not propose to undertake formal hypothesis tests of the
primary or secondary endpoints for the definitive trial.
Qualitative analysis
Thematic analysis [45] will be used to extract emerging
themes and variations. Concurrent data collection and
analysis will be undertaken using multi-layered reading
and constant comparison [46]. N-vivo 10.0 software will
be used for data management. An audit trail, detailed
field notes, and memos will be maintained throughout
the research process.
Sample size and power
Sample size for the pilot study is determined based on
the recommended sample size of approximately 40 par-
ticipants for a pilot study [47]. Approximately 20 pa-
tients are referred for breast reconstruction per surgeon
per month. Workshops and clinics have the capacity for
five and ten patients per session, respectively. A conser-
vative estimate of 50-70% recruitment would allow us to
recruit our pilot sample size over 6 months across four
clinics.
Interpretation of pilot results
Feasibility targets include ≥ 60% recruitment, ≥ 80% re-
tention after randomized treatment assignment, and
≥ 80% completion of primary outcome measure. Suc-
cess will also be measured based on high treatment
fidelity measured through observation of the interven-
tion and participant qualitative report. To inform our de-
cision for the primary outcome for a definitive RCT, the
most important outcome measure for patients will be
solicited and ascertained through qualitative methods.
Discussion
To reduce unnecessary variation in treatment and im-
prove quality of cancer care among breast cancer pa-
tients, there has been a growing interest in engaging
patients through the decision-making process [48,49].
Particularly for breast reconstruction there is a paucity
of studies designed to address patients’ unique informa-
tional and supportive-care needs, and there has been a
call to action to develop and implement interventions
that enhance patient empowerment [50]. Only one RCT
has designed and implemented a decision support inter-
vention for patients considering breast reconstruction
[51]. While patients assigned to the pre-consultation
computer-based decision support intervention demon-
strated greater knowledge scores, outcomes related to
shared decision-making or decision quality were not
assessed using validated instruments [51]. Retrospectiveobservational studies from single institutions suggest
that well-informed patients already participate in the de-
cision whether or not to undergo breast reconstruction
[12,41], but interventions can improve involvement and
satisfaction for the decision regarding the type of recon-
struction (implant-based or autologous tissue recon-
struction) among women who decided to have breast
reconstruction [52]. However, inferences regarding the
utility of decision-support interventions for breast re-
construction patients from non-randomized and particu-
larly retrospective studies must be made with caution.
Furthermore, no study has examined the potential of
group workshops to enhance patient engagement and
decision quality; educational interventions delivered in a
group setting have been demonstrated to be an effective
tool to address informational and psychosocial needs for
breast cancer survivors [30]. Therefore, we designed a
novel intervention to address identified gaps in care to
promote shared decision-making and improve the quality
of patient decisions surrounding breast reconstruction.
Because the intervention occurs before the initial surgi-
cal consultation (necessitating telephone recruitment)
and is delivered using a novel format in a group setting,
we felt it would be most appropriate to first undertake a
pilot study prior to a definitive trial. Our pilot study
seeks to identify (1) the feasibility, acceptability, and de-
sign of a definitive RCT and (2) the optimal content and
delivery of our proposed educational group intervention.
Results from our pilot study will be used in the following
two ways: (1) to validate the design of the intervention
and revise content and delivery to meet the needs of the
end-users; (2) to inform the final design and sample size
estimation for a definitive RCT.Trial status
The pre-consultation educational group intervention
pilot trial began recruitment in January 2013. Thirty pa-
tients have been recruited to date (18 May 2013), of
whom 15 have been randomized to one of three decision
support workshops. Once all participants have been
recruited and enrolled, we will complete qualitative in-
terviews among a purposeful sample of voluntary partic-
ipants. Recruitment is ongoing, and the trial is
scheduled to be completed by the end of this academic
year (June 2013).
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